Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (10)

2023

  1. Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study

    Journal of the American Academy of Dermatology, Vol. 89, Núm. 1, pp. 119-127

2022

  1. Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study

    Cancers, Vol. 14, Núm. 4

2021

  1. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis

    Nature, Vol. 589, Núm. 7842, pp. 448-455

2020

  1. Diagnosis and Treatment of Basal Cell Carcinoma in Specialized Dermatology Units: A Clinical Practice Guideline

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 4, pp. 291-299

2019

  1. Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients. A prospective multicentre cohort study

    Journal of the European Academy of Dermatology and Venereology, Vol. 33, Núm. 5, pp. 857-862

2015

  1. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: A randomised, investigator-blinded, controlled, phase III study throughout Europe

    Journal of the European Academy of Dermatology and Venereology, Vol. 29, Núm. 12, pp. 2342-2348

  2. Reply to: "topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations - Anatomical differences in response to PDL are relevant to interpretation of study results"

    Journal of the American Academy of Dermatology

  3. Spanish-Portuguese Consensus Statement on Use of Daylight-Mediated Photodynamic Therapy with Methyl Aminolevulinate in the Treatment of Actinic Keratosis

    Actas Dermo-Sifiliograficas, Vol. 106, Núm. 8, pp. 623-631

  4. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: Phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial

    Journal of the American Academy of Dermatology, Vol. 72, Núm. 1, pp. 151-158.e1

2013

  1. Registro nacional de melanoma cutáneo. Características del tumor en el momento del diagnóstico: 15 años de experiencia

    Actas Dermo-Sifiliograficas, Vol. 104, Núm. 9, pp. 789-799